Cargando…

Could Immunoglobulin Level Be a Prognostic Factor for Coronary Artery Lesions in Kawasaki Diseases?

Detalles Bibliográficos
Autor principal:	Han, Mi Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Cardiology 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925965/ https://www.ncbi.nlm.nih.gov/pubmed/33655728 http://dx.doi.org/10.4070/kcj.2021.0046

Ejemplares similares

Predictive factors of resistance to intravenous immunoglobulin and coronary artery lesions in Kawasaki disease
por: Lee, Hye Young, et al.
Publicado: (2016)

Factors Predicting Resistance to Intravenous Immunoglobulin and Coronary Complications in Kawasaki Disease: IVIG Resistance in Kawasaki Disease
por: Han, Ji Whan
Publicado: (2017)

Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease
por: Xie, Tian, et al.
Publicado: (2017)

Prognosis and Risk Factors of Coronary Artery Lesions before Immunoglobulin Therapy in Children with Kawasaki Disease
por: Qiu, Huixian, et al.
Publicado: (2020)

IgA Levels Are Associated with Coronary Artery Lesions in Kawasaki Disease
por: Kim, Jae-Jung, et al.
Publicado: (2021)

Can iron be a risk factor for coronary lesions in Kawasaki disease?
por: Yoon, Kyung Lim
Publicado: (2019)

Risk Factors Related to Coronary Artery Outcome in Kawasaki Disease
por: Kim, Soo-Jin
Publicado: (2018)

Predictive risk factors of coronary artery aneurysms in Kawasaki disease
por: Woo, Hyang-Ok
Publicado: (2019)

Significantly Lower Immunoglobulin M Levels 6 Months After Disease Onset in Patients With Kawasaki Disease With Coronary Artery Lesions
por: Chang, Ling‐Sai, et al.
Publicado: (2021)

Insights Into Coronary Artery Lesions in Kawasaki Disease
por: Zhang, Danfeng, et al.
Publicado: (2020)

Prognostic nutritional index value in the prognosis of Kawasaki disease with coronary artery lesions
por: Liu, Jie, et al.
Publicado: (2023)

The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease?
por: Han, Ji Whan
Publicado: (2017)

High antistreptolysin O titer is associated with coronary artery lesions in patients with Kawasaki disease
por: Min, Dong Eun, et al.
Publicado: (2019)

Non-Responders to Intravenous Immunoglobulin and Coronary Artery Dilatation in Kawasaki Disease: Predictive Parameters in Korean Children
por: Kim, Bo Young, et al.
Publicado: (2016)

Analysis of the Risk Factors in Prognosis of Kawasaki Disease With Coronary Artery Lesions
por: Hu, Jinling, et al.
Publicado: (2021)

Clinically Useful Predictors of Resistance to Intravenous Immunoglobulin and Prognosis of Coronary Artery Lesions in Patients with Incomplete Kawasaki Disease
por: Cho, Kee Hyun, et al.
Publicado: (2014)

C-Reactive Protein to Albumin Ratio for Predicting Coronary Artery Lesions and Intravenous Immunoglobulin Resistance in Kawasaki Disease
por: Tsai, Chih-Min, et al.
Publicado: (2020)

Clinical manifestations and risk factors of coronary artery lesions in children with Kawasaki disease
por: Wang, Ling, et al.
Publicado: (2023)

Kawasaki Disease With Coronary Artery Lesions Detected at Initial Echocardiography
por: Ae, Ryusuke, et al.
Publicado: (2021)

Nomogram for predicting coronary artery lesions in patients with Kawasaki disease
por: Chen, Jie, et al.
Publicado: (2023)

Significance of Coronary Revascularization for Coronary-Artery Obstructive Lesions Due to Kawasaki Disease
por: Kitamura, Soichiro, et al.
Publicado: (2019)

Is there an association between intravenous immunoglobulin resistance and coronary artery lesion in Kawasaki disease?—Current evidence based on a meta-analysis
por: Zheng, Xiaolan, et al.
Publicado: (2021)

Neutropenia after intravenous immunoglobulin therapy is associated with coronary artery lesions in children with Kawasaki disease: a case control study
por: Wang, Zhenquan, et al.
Publicado: (2018)

Albumin level and progression of coronary artery lesions in Kawasaki disease: A retrospective cohort study
por: Xia, Yuhan, et al.
Publicado: (2022)

IL-31 Associated with Coronary Artery Lesion Formation in Kawasaki Disease
por: Tseng, Wan-Ning, et al.
Publicado: (2014)

Gene-Gene Associations with the Susceptibility of Kawasaki Disease and Coronary Artery Lesions
por: Kuo, Ho-Chang, et al.
Publicado: (2015)

Association between Adipokines and Coronary Artery Lesions in Children with Kawasaki Disease
por: Kim, Hyun Jung, et al.
Publicado: (2014)

Preventing coronary artery lesions in Kawasaki disease [Image: see text]
por: Kuo, Ho-Chang
Publicado: (2017)

Plasma Prostaglandin E(2) Levels Correlated with the Prevention of Intravenous Immunoglobulin Resistance and Coronary Artery Lesions Formation via CD40L in Kawasaki Disease
por: Kuo, Ho-Chang, et al.
Publicado: (2016)

The occurrence of coronary artery lesions in Kawasaki disease based on C-reactive protein levels: a retrospective cohort study
por: An, Hyo Soon, et al.
Publicado: (2021)

Factors Predicting Resistance to Intravenous Immunoglobulin Treatment and Coronary Artery Lesion in Patients with Kawasaki Disease: Analysis of the Korean Nationwide Multicenter Survey from 2012 to 2014
por: Kim, Min Kyu, et al.
Publicado: (2017)

Affects of "Age at Diagnosis" on Coronary Artery Lesions in Patients With Incomplete Kawasaki Disease
por: Cho, Min A, et al.
Publicado: (2010)

CD36 is Associated With the Development of Coronary Artery Lesions in Patients With Kawasaki Disease
por: Guo, Mindy Ming-Huey, et al.
Publicado: (2022)

Correlation Between Matrix Metalloproteinases With Coronary Artery Lesion Caused by Kawasaki Disease
por: Tian, Fang, et al.
Publicado: (2022)

The role of Annexin A3 in coronary arterial lesions in children with Kawasaki disease
por: Li, Mengling, et al.
Publicado: (2023)

Association between FGA gene polymorphisms and coronary artery lesion in Kawasaki disease
por: Liu, Xingzhu, et al.
Publicado: (2023)

Late development of coronary artery abnormalities could be associated with persistence of non-fever symptoms in Kawasaki disease
por: Fukuda, Sayaka, et al.
Publicado: (2013)

The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease
por: Chang, Ling-Sai, et al.
Publicado: (2016)

Serum ferritin as a crucial biomarker in the diagnosis and prognosis of intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease: A systematic review and meta-analysis
por: Wen, Huai, et al.
Publicado: (2022)

Coronary artery aneurysm in Kawasaki disease
por: Donuru, Achala, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vf7qv1nhhojhlt02ct5kghqk4u